Experiences with interferon-beta-1b treatment in MS after three year follow-up.
Bencsik
Krisztina
K
Rajda
Cecilia
C
Füvesi
Judit
J
Járdánházy
Tamás
T
Török
Margit
M
Vécsei
László
L
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D017327:Clinical Trials, Phase IV as Topic; D005500:Follow-Up Studies; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a